鼻内手术后继发颈内动脉损伤的血管内治疗:病例系列与文献综述
该研究回顾性分析了576例经蝶窦垂体腺瘤切除术,其中5例(0.9%)发生颈内动脉损伤,另纳入2例外院转入病例,共7例接受血管内治疗。结合文献98例,总计105例分析显示:血管牺牲46例,病变栓塞28例,腔内重建31例。作者提出基于血管解剖、损伤特征和双联抗血小板治疗风险的治疗算法,但需更多研究(尤其血流导向装置)完善决策。
要点
- 经蝶窦手术后颈内动脉损伤发生率为0.9%(5/576),血管内治疗包括血管牺牲、栓塞和腔内重建。
- 血管牺牲46例中持续性神经并发症10例(21.7%),但止血持久。
- 覆膜支架技术并发症10/24(41.7%),其中8例解决,重大技术并发症2/24(8.3%)。
核心结论
- 血管内治疗(血管牺牲、弹簧圈栓塞伴或不伴支架辅助、腔内重建)为鼻内手术后颈内动脉损伤提供个体化方案。
- 血管牺牲仍是急性不可控出血的确定性治疗,但血管保留技术应在特定患者中仔细考虑。
- 血管解剖、损伤特征和双联抗血小板治疗风险等多因素应指导最佳治疗,但需更多研究(尤其血流导向装置)完善决策。
- 理想情况下,所有血管内治疗选项应在开展鼻内手术的机构可用。
研究设计与样本
- 回顾性研究:回顾性分析576例经蝶窦垂体腺瘤切除术,评估本院发生的颈内动脉损伤病例及外院转入病例。
- 文献综述:回顾并总结文献中报道的颈内动脉损伤血管内治疗病例。
- 样本:本院队列7例(平均年龄46.3岁,平均随访43.4个月[范围1-107个月]),其中5例(0.9%)发生在本院,2例发生在外院;文献回顾98例;总计105例。
主要发现
- 本院7例中,3例行弹簧圈置入血管牺牲,2例行病变栓塞(弹簧圈或支架辅助弹簧圈),2例行腔内重建(均使用血流导向装置)。
- 文献98例中,46例行血管牺牲,28例行病变栓塞,31例行腔内重建;总计105例中分别为46、28、31例。
- 血管牺牲在所有病例中均为持久解决方案,但持续性神经并发症率为10/46(21.7%)。
- 病变栓塞主要采用单纯弹簧圈栓塞(16例)和支架辅助弹簧圈(9例),两者至少某种技术并发症率分别为6/16(37.5%)和5/9(55.6%),重大技术并发症(损伤、新发神经功能缺损或颈内动脉牺牲)率分别为5/16(31.3%)和2/9(22.2%)。
- 腔内重建采用覆膜支架(24例)和血流导向装置(5例);覆膜支架技术并发症率为10/24(41.7%),其中8例问题解决,重大技术并发症率为2/24(8.3%);血流导向装置仅1例轻微技术并发症。
临床怎么用
- 作者认为血管内治疗(包括血管牺牲、弹簧圈栓塞伴或不伴支架辅助、腔内重建)为鼻内手术后颈内动脉损伤提供个体化方案。
- 作者指出血管牺牲仍是急性不可控出血的确定性治疗,但血管保留技术应在特定患者中仔细考虑。
- 作者建议血管解剖、损伤特征和双联抗血小板治疗风险等多因素应指导最佳治疗,但需更多研究(尤其血流导向装置)完善决策。
- 作者认为理想情况下所有血管内治疗选项应在开展鼻内手术的机构可用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Internal carotid artery (ICA) injury is a rare but severe complication of endonasal surgery. The authors describe their endovascular experience managing ICA injuries after transsphenoidal surgery; they review and summarize the current literature regarding endovascular techniques; and they propose a treatment algorithm based on the available evidence. METHODS A retrospective review of 576 transsphenoidal pituitary adenoma resections was performed. Cases of ICA injury occurring at our institution and transfers from other hospitals were evaluated. Endovascular treatments for ICA injury reported in the literature were also reviewed and summarized. RESULTS Seven cases were identified from the institutional cohort (mean age 46.3 years, mean follow-up 43.4 months [1-107 months]) that received endovascular treatment for ICA injury. Five injuries occurred at our institution (5 [0.9%] of 576), and 2 injuries occurred at outside hospitals. Three patients underwent ICA sacrifice by coil placement, 2 underwent lesion embolization (coil or stent-assisted coil placement), and 2 underwent endoluminal reconstruction (both with flow diversion devices). Review of the literature identified 98 cases of ICA injury treated with endovascular methods. Of the 105 total cases, 46 patients underwent ICA sacrifice, 28 underwent lesion embolization, and 31 underwent endoluminal reconstruction. Sacrifice of the ICA proved a durable solution in all cases; however, the rate of persistent neurological complications was relatively high (10 [21.7%] of 46). Lesion embolization was primarily performed by coil embolization without stenting (16 cases) and stent-assisted coiling (9 cases). Both techniques had a relatively high rate of at least some technical complication (6 [37.5%] of 16 and 5 [55.6%] of 9, respectively) and major technical complications (i.e., injury, new neurological deficit, or ICA sacrifice) (5 [31.3%] of 16 and 2 [22.2%] of 9, respectively). Endoluminal reconstruction was performed by covered stent (24 cases) and flow diverter (5 cases) placement. Covered stents showed a reasonably high rate of technical complications (10 [41.7%] of 24); however, 8 of these problems were resolved, leaving a small percentage with major technical complications (2 [8.3%] of 24). Flow diverter placement was also well tolerated, with only 1 minor technical complication. CONCLUSIONS Endovascular treatments including vessel sacrifice, coil embolization (with or without stent assistance), and endoluminal reconstruction offer a tailored approach to ICA injury management after endonasal surgery. Vessel sacrifice remains the definitive treatment for acute, uncontrolled bleeding; however, vessel preservation techniques should be considered carefully in select patients. Multiple factors including vascular anatomy, injury characteristics, and risk of dual antiplatelet therapy should guide best treatment, but more study is needed (particularly with flow diverters) to refine this decision-making process. Ideally, all endovascular treatment options should be available at institutions performing endonasal surgery.
引用
- Sylvester PT, Moran CJ, Derdeyn CP, et al. Endovascular management of internal carotid artery injuries secondary to endonasal surgery: case series and review of the literature. J Neurosurg. 2016. PMID: 26771847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。